Similar Papers

Paper Title
Journal
Date
Author
PACIFIC: Time for a surgical IIIA uprising
Harvey I Pass
The Journal of Thoracic and Cardiovascular Surgery | VOL. 156
Harvey I PassHarvey I Pass
04 Jun 2018
Impact of the new EGF receptor and ALK testing guideline on personalized lung cancer medicine.
Miguel A Molina-Vila ... Carlota Costa
Personalized Medicine | VOL. 10
Miguel A Molina-Vila, et. al.Miguel A Molina-Vila ... Carlota Costa
01 Jul 2013
KRAS and BRAF Double Mutations and Functional Classes of BRAF Mutations in Non–small-cell Lung Cancers
Amélie Bourhis ... Arnaud Uguen
Clinical Lung Cancer | VOL. 21
Amélie Bourhis, et. al.Amélie Bourhis ... Arnaud Uguen
28 Feb 2020
Abstract PL04-01: Improving patient outcomes in lung cancer by targeting different driver mutations
Bruce E Johnson
Cancer Research | VOL. 71
Bruce E JohnsonBruce E Johnson
15 Apr 2011
View more papers

More From: AME Clinical Trials Review

Paper Title
Journal
Date
Author
Drug-coated ballons finally land in the United States: an appraisal of the agent IDE randomized clinical trial
Filippo Luca Gurgoglione ... Bernardo Cortese
AME Clinical Trials Review | VOL. 2
Filippo Luca Gurgoglione, et. al.Filippo Luca Gurgoglione ... Bernardo Cortese
01 Dec 2024
Antiplatelet therapy after coronary artery bypass surgery: the results from the randomized DACAB trial
Paolo Nardi ... Augusto D’Onofrio
AME Clinical Trials Review | VOL. 2
Paolo Nardi, et. al.Paolo Nardi ... Augusto D’Onofrio
01 Dec 2024
Less radiation, same bang, fewer bucks?
Scott I Reznik ... John Keene Waters
AME Clinical Trials Review | VOL. 2
Scott I Reznik, et. al.Scott I Reznik ... John Keene Waters
01 Dec 2024
The COMBAT trial: use of bipolar androgen therapy to enhance immune checkpoint blockade in the management of metastatic castration-resistant prostate cancer
Harshraj Leuva ... Benjamin A Teply
AME Clinical Trials Review | VOL. 2
Harshraj Leuva, et. al.Harshraj Leuva ... Benjamin A Teply
01 Dec 2024
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.